FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Pfister

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Geographic Areas

United States

Co-author Network

Publications

TOP 3
Matthew G Fury; Sofia Haque; Adrian Heguy; Alan L Ho; Nora Katabi; Oby Nwankwo; Eric Sherman; Camelia Sima; Frank Tsai; Han Xiao; David G Pfister
A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer.
Eric J Sherman; Yungpo Bernard Su; R Michael Tuttle; Heiko Schöder; Ashok R Shaha; Matthew G Fury; Ronald A Ghossein; Sofia Haque; Donna Lisa; Ashima Lyall; David G Pfister
Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinoma.
Alan L Ho; Steve M Larson; Rebecca Leboeuf; Keith S Pentlow; David G Pfister; Julio C Ricarte-Filho; Ronglai Shen; Eric J Sherman; R Michael Tuttle; Pat B Zanzonico; Somali Gavane; Ronald A Ghossein; Ravinder K Grewal; Sofia Haque; Desiree Deandreis; José M Domínguez; James A Fagin
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Pfister (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Matthew G Fury; Sofia Haque; Adrian Heguy; Alan L Ho; Nora Katabi; Oby Nwankwo; Eric Sherman; Camelia Sima; Frank Tsai; Han Xiao; David G Pfister
A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer.
Cancer 2013;119(10):1823-31.
2013: Eric J Sherman; Yungpo Bernard Su; R Michael Tuttle; Heiko Schöder; Ashok R Shaha; Matthew G Fury; Ronald A Ghossein; Sofia Haque; Donna Lisa; Ashima Lyall; David G Pfister
Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinoma.
Thyroid : official journal of the American Thyroid Association 2013;23(5):593-9.
2013: Alan L Ho; Steve M Larson; Rebecca Leboeuf; Keith S Pentlow; David G Pfister; Julio C Ricarte-Filho; Ronglai Shen; Eric J Sherman; R Michael Tuttle; Pat B Zanzonico; Somali Gavane; Ronald A Ghossein; Ravinder K Grewal; Sofia Haque; Desiree Deandreis; José M Domínguez; James A Fagin
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.
The New England journal of medicine 2013;368(7):623-32.
2012: Matthew G Fury; Sofia Haque; Susan Korte; Corey Langer; Dean Lim; Brynna Lipson; Donna Lisa; Ranee Mehra; Kenneth Ng; Sandeep K Rajan; Eric Sherman; Stephanie Smith-Marrone; Tawee Tanvetyanon; Han Xiao; Furhan Yunus; Neeraj Agarwal; Kenneth Algazy; Bruce Brockstein; David G Pfister
A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2012;10(11):1391-8.
2012: Matthew G Fury; Sofia Haque; Katherine Kelly; Dennis Kraus; Nancy Y Lee; Brynna Lipson; Donna Lisa; Jatin Shah; Ronglai Shen; Eric Sherman; Hilda E Stambuk; Diane Carlson; David G Pfister
A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer.
Cancer 2012;118(20):5008-14.
2012: Shyam D Rao; Matthew G Fury; David G Pfister
Molecular-targeted therapies in head and neck cancer.
Seminars in radiation oncology 2012;22(3):207-13.
2012: Matthew G Fury; Sofia Haque; Alan Ho; Nora Katabi; Katherine W Kelly; Oby Nwankwo; Eric Sherman; Camelia Sima; David G Pfister
A phase I study of temsirolimus plus carboplatin plus paclitaxel for patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC).
Cancer chemotherapy and pharmacology 2012;70(1):121-8.
2012: Shrujal S Baxi; Karen T Brown; Ronald P DeMatteo; Katherine W Kelly; Eric J Sherman; David G Pfister
Hemorrhagic pseudoaneurysm in a patient receiving aflibercept for metastatic thyroid cancer.
Thyroid : official journal of the American Thyroid Association 2012;22(5):552-5.
2012: Eric J Sherman; Bhuvanesh Singh; Gregory T Wolf; Michael J Zelefsky; Susan G Fisher; Dennis H Kraus; Venkatraman E Seshan; Jatin P Shah; Ashok R Shaha; David G Pfister
TALK score: Development and validation of a prognostic model for predicting larynx preservation outcome.
The Laryngoscope 2012;122(5):1043-50.
2012: Benjamin H Lok; Jeffery Park; David G Pfister; Shyam D Rao; Jonathan Romanyshyn; Nicholas Rowan; Karen Schupak; Jeremy Setton; Jatin P Shah; Eric Sherman; Suzanne L Wolden; Richard J Wong; Michael J Zelefsky; Zhigang Zhang; Nicola Caria; Matthew G Fury; DY Gelblum; Alan Ho; Dennis H Kraus; Nancy Y Lee
Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes.
International journal of radiation oncology, biology, physics 2012;82(5):1851-7.
2012: Amita Dave; Hilda E Stambuk; Howard T Thaler; Ya Wang; Matthew G Fury; Jacobus F A Jansen; Sasan Karimi; Dennis Kraus; Nancy Y Lee; Andre L Moreira; Snehal G Patel; David G Pfister; Jatin P Shah; Eric Sherman; Jason A Koutcher
Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases.
International journal of radiation oncology, biology, physics 2012;82(5):1837-44.
2012: David G Pfister
Off-label use of oncology drugs: the need for more data and then some.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(6):584-6.
2012: Nancy Y Lee; James Mechalakos; David G Pfister; Qiang Zhang; Anthony Tc Chan; A Dimitrios Colevas; Adam S Garden; Bonnie S Glisson; Kenneth Hu; John Kim; Quynh T Le; K. Kian Ang
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial.
The lancet oncology 2012;13(2):172-80.
2011: Eric J Sherman; Suzanne Wolden; Michael Rivera; Ashok R Shaha; Matthew G Fury; Ronald A Ghossein; Alan L Ho; Nancy Y Lee; Su Hsien Lim; Oscar Lin; David G Pfister
Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2011;101(3):425-30.
2011: Lawrence Koutcher; Dennis Kraus; Matthew G Fury; DY Gelblum; Qianxing Mo; David G Pfister; Karen Schupak; Jatin Shah; Eric Sherman; Laschelle Stewart; Suzanne L Wolden; Richard Wong; Melvin Zelefsky; Zhigang Zhang; Nancy Lee
Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer.
International journal of radiation oncology, biology, physics 2011;81(4):915-22.
2011: Ian Ganly; Nancy Lee; David G Pfister; Jatin P Shah; Jennifer Bocker; Diane L Carlson; Maria Coleman; Salvatore D'Arpa; Snehal G Patel
Viable tumor in postchemoradiation neck dissection specimens as an indicator of poor outcome.
Head & neck 2011;33(10):1387-93.
2011: Christopher G Azzoli; Sherman Baker; Julie R Brahmer; Giuseppe Giaccone; David H Johnson; Janessa L Laskin; Gregory Masters; Daniel Milton; Luke Nordquist; William Pao; David G Pfister; Steven Piantadosi; Joan H Schiller; Reily Smith; Thomas J Smith; John R Strawn; Sarah Temin; David Trent; Timothy B Aliff
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(28):3825-31.
2011: Matthew G Fury; Nancy Lee; Marina Asher; Diane Carlson; Marija Drobnjak; Jatin Shah; Camelia S Sima; H Guido Wendel; David G Pfister
Tissue microarray evidence of association between p16 and phosphorylated eIF4E in tonsillar squamous cell carcinoma.
Head & neck 2011;33(9):1340-5.
2011: Razelle Kurzrock; Ranee Mehra; Thomas Müller; Forlisa Nauling; Chaan S Ng; David G Pfister; Mark J Ratain; Douglas W Ball; Ezra E W Cohen; Roger B Cohen; Arlene A Forastiere; John Frye; Robert F Gagel; David S Hong; Linda Janisch; Steven I Sherman; Lei Ye; Ravi Salgia
Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(19):2660-6.
2011: Matthew G Fury; David G Pfister
Current recommendations for systemic therapy of recurrent and/or metastatic head and neck squamous cell cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2011;9(6):681-9.
2011: Richard L Bakst; Nancy Lee; David G Pfister; Michael J Zelefsky; Margie A Hunt; Dennis H Kraus; Suzanne L Wolden
Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial.
International journal of radiation oncology, biology, physics 2011;80(1):148-53.
2011: Matthew G Fury; Sofia Haque; Hilda E Stambuk; Ronglai Shen; Diane Carlson; David G Pfister
A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer.
Cancer 2011;117(4):795-801.
2011: Matthew G Fury; Shrujal Baxi; Ronglai Shen; Katherine W Kelly; Brynna L Lipson; Diane Carlson; Hilda E Stambuk; Sofia Haque; David G Pfister
Phase II study of saracatinib (AZD0530) for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).
Anticancer research 2011;31(1):249-53.
2010: Jacobus F A Jansen; Heiko Schöder; Nancy Y Lee; Ya Wang; David G Pfister; Matthew G Fury; Hilda E Stambuk; John L Humm; Jason A Koutcher; Amita Dave
Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases.
International journal of radiation oncology, biology, physics 2010;77(5):1403-10.
2010: James A Fagin; R Michael Tuttle; David G Pfister
Harvesting the low-hanging fruit: kinase inhibitors for therapy of advanced medullary and nonmedullary thyroid cancer.
The Journal of clinical endocrinology and metabolism 2010;95(6):2621-4.
2010: David G Pfister; Barrie R Cassileth; Gary Deng; K Simon Yeung; Jennifer S Lee; Donald Garrity; Angel Cronin; Nancy Y Lee; Dennis H Kraus; Ashok R Shaha; Jatin P Shah; Andrew J Vickers
Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(15):2565-70.
2010: Christopher G Azzoli; Sherman Baker; Sarah Temin; William Pao; Timothy Aliff; Julie R Brahmer; David H Johnson; Janessa L Laskin; Gregory Masters; Daniel Milton; Luke Nordquist; David G Pfister; Steven Piantadosi; Joan H Schiller; Reily Smith; Thomas J Smith; John R Strawn; David Trent; Giuseppe Giaccone
[American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer].
Zhongguo fei ai za zhi = Chinese journal of lung cancer 2010;13(3):171-89.
2010: Samuel A Wells; Jessica E Gosnell; Robert F Gagel; Jeffrey Moley; David G Pfister; Julie A Sosa; Michael Skinner; Annetta Krebs; James Vasselli; Martin Schlumberger
Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(5):767-72.
2010: Lawrence Koutcher; Nancy Y Lee; Michael J Zelefsky; Kelvin Chan; Gilad Cohen; David G Pfister; Dennis H Kraus; Suzanne L Wolden
Reirradiation of locally recurrent nasopharynx cancer with external beam radiotherapy with or without brachytherapy.
International journal of radiation oncology, biology, physics 2010;76(1):130-7.
2009: Christopher G Azzoli; Sherman Baker; Sarah Temin; William Pao; Timothy Aliff; Julie R Brahmer; David H Johnson; Janessa L Laskin; Gregory Masters; Daniel Milton; Luke Nordquist; David G Pfister; Steven Piantadosi; Joan H Schiller; Reily Smith; Thomas J Smith; John R Strawn; David Trent; Giuseppe Giaccone
American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(36):6251-66.
2009: Nicholas J Petrelli; Eric P Winer; Julie R Brahmer; Sarita Dubey; Sonali Smith; Charles Thomas; Linda Vahdat; Jennifer Obel; Nicholas Vogelzang; Maurie Markman; John W Sweetenham; David G Pfister; Mark G Kris; Lynn Schuchter; Raymond Sawaya; Derek Raghavan; Patricia Anne Ganz; Barnett Kramer
Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(35):6052-69.
2009: Ian Ganly; Snehal G Patel; Jeannette Marie S Matsuo; Bhuvanesh Singh; Dennis H Kraus; Jay O Boyle; Richard J Wong; Nancy Y Lee; David G Pfister; Ashok R Shaha; Jatin P Shah
Predictors of outcome for advanced-stage supraglottic laryngeal cancer.
Head & neck 2009;31(11):1489-95.
2009: Aleksandra Raykher; Lilia Correa; Lianne Russo; Pat Brown; Nancy Y Lee; David G Pfister; Hans Gerdes; Jatin P Shah; Dennis H Kraus; Mark Schattner; Moshe Shike
The role of pretreatment percutaneous endoscopic gastrostomy in facilitating therapy of head and neck cancer and optimizing the body mass index of the obese patient.
JPEN. Journal of parenteral and enteral nutrition 2009;33(4):404-10.
2009: Daniel R Gomez; Joanne Zhung; Jennifer Gomez; Kelvin Chan; Abraham J Wu; Suzanne L Wolden; David G Pfister; Ashok R Shaha; Jatin P Shah; Dennis H Kraus; Richard J Wong; Nancy Y Lee
Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers.
International journal of radiation oncology, biology, physics 2009;73(4):1096-103.
2009: Stephanie Terezakis; Kyungmouk S Lee; Ronald A Ghossein; Michael Rivera; R Michael Tuttle; Suzanne L Wolden; Michael J Zelefsky; Richard J Wong; Snehal G Patel; David G Pfister; Ashok R Shaha; Nancy Y Lee
Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience.
International journal of radiation oncology, biology, physics 2009;73(3):795-801.
2009: Eric Winer; Julie Gralow; Lisa Diller; Beth Y Karlan; Patrick Loehrer; Lori J Pierce; George Demetri; Patricia Anne Ganz; Barnett Kramer; Mark G Kris; Maurie Markman; Robert Mayer; David G Pfister; Derek Raghavan; Scott Ramsey; Gregory Reaman; Howard Sandler; Raymond Sawaya; Lynn Schuchter; John Sweetenham; Linda Vahdat; Richard L Schilsky
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(5):812-26.
2009: Luzius A Steiner; David G Pfister; Stephan P Strebel; Danila Radolovich; Piotr Smielewski; Marek Czosnyka
Near-infrared spectroscopy can monitor dynamic cerebral autoregulation in adults.
Neurocritical care 2009;10(1):122-8.
2008: Bradford Hoppe; Carl J Nelson; Daniel R Gomez; Lauren D Stegman; Abraham J Wu; Suzanne L Wolden; David G Pfister; Michael J Zelefsky; Jatin P Shah; Dennis H Kraus; Nancy Y Lee
Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities.
International journal of radiation oncology, biology, physics 2008;72(3):763-9.
2008: David G Pfister; James A Fagin
Refractory thyroid cancer: a paradigm shift in treatment is not far off.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(29):4701-4.
2008: Ramesh Rengan; David G Pfister; Nancy Y Lee; Dennis H Kraus; Jatin P Shah; Ashok R Shaha; Leah S Ben-Porat; Michael J Zelefsky
Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer.
American journal of clinical oncology 2008;31(5):465-9.
2008: C-H Ohlmann; E Markert; M Gerharz; David G Pfister; H-P Dienes; Udo Engelmann; A Heidenreich
[Feasibility of targeted therapy based on immunohistochemical expression analysis in androgen-independent prostate cancer].
Der Urologe. Ausg. A 2008;47(9):1218-23.
2008: Arlene A Forastiere; Kie-Kian Ang; David Brizel; Bruce E Brockstein; Barbara A Burtness; Anthony J Cmelak; Alexander D Colevas; Frank Dunphy; David W Eisele; Helmuth Goepfert; Wesley L Hicks; Merrill S Kies; William M Lydiatt; Ellie Maghami; Renato Martins; Thomas McCaffrey; Bharat B Mittal; David G Pfister; Harlan A Pinto; Marshall R Posner; John A Ridge; Sandeep Samant; David E Schuller; Jatin P Shah; Sharon Spencer; Andy Trotti; Randal S Weber; Gregory T Wolf; Frank Worden
Head and neck cancers.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(7):646-95.
2008: Bhuvanesh Singh; David G Pfister
Individualized treatment selection in patients with head and neck cancer: do molecular markers meet the challenge?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(19):3114-6.
2008: Seng Chuan Ong; Heiko Schöder; Nancy Y Lee; Snehal G Patel; Diane Carlson; Matthew G Fury; David G Pfister; Jatin P Shah; Steven M Larson; Dennis H Kraus
Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(4):532-40.
2008: Michelle L Klem; James Mechalakos; Suzanne L Wolden; Michael J Zelefsky; Bhuvanesh Singh; Dennis H Kraus; Ashok R Shaha; Jatin P Shah; David G Pfister; Nancy Y Lee
Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
International journal of radiation oncology, biology, physics 2008;70(4):1100-7.
2008: Axel Heidenreich; David G Pfister; Carsten-Henning Ohlmann; Udo Engelmann
[Androgen deprivation for advanced prostate cancer].
Der Urologe. Ausg. A 2008;47(3):270-83.
2008: Matthew G Fury; Allan Lipton; Katherine M Smith; Corinne Winston; David G Pfister
A phase-I trial of the epidermal growth factor receptor directed bispecific antibody MDX-447 without and with recombinant human granulocyte-colony stimulating factor in patients with advanced solid tumors.
Cancer immunology, immunotherapy : CII 2008;57(2):155-63.
2008: David G Pfister; B Schmidt; Piotr Smielewski; Martin Siegemund; Stephan Strebel; Stephan Rüegg; Stephan Marsch; Hans Pargger; Luzius A Steiner
Intracranial pressure in patients with sepsis.
Acta neurochirurgica. Supplement 2008;102():71-5.
2008: David G Pfister; Martin Siegemund; Salome Dell-Kuster; Piotr Smielewski; Stephan Rüegg; Stephan P Strebel; Stephan C U Marsch; Hans Pargger; Luzius A Steiner
Cerebral perfusion in sepsis-associated delirium.
Critical care (London, England) 2008;12(3):R63.
2008: David G Pfister; Stephan Strebel; Luzius A Steiner
Effects of catecholamines on cerebral blood vessels in patients with traumatic brain injury.
European journal of anaesthesiology. Supplement 2008;42():98-103.
2007: David G Pfister; Stephan P Strebel; Luzius A Steiner
Postoperative management of adult central neurosurgical patients: systemic and neuro-monitoring.
Best practice & research. Clinical anaesthesiology 2007;21(4):449-63.
2007: Nancy Y Lee; William O'Meara; Kelvin Chan; Cesar Della-Bianca; James Mechalakos; Joanne Zhung; Suzanne L Wolden; Ashwatha Narayana; Dennis H Kraus; Jatin P Shah; David G Pfister
Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
International journal of radiation oncology, biology, physics 2007;69(2):459-68.
2007: Nancy Y Lee; Kelvin Chan; Justin E Bekelman; Joanne Zhung; James Mechalakos; Ashwatha Narayana; Suzanne L Wolden; Venkatraman E Seshan; David G Pfister; Dennis H Kraus; Jatin P Shah; Michael J Zelefsky
Salvage re-irradiation for recurrent head and neck cancer.
International journal of radiation oncology, biology, physics 2007;68(3):731-40.
2007: Christopher G Azzoli; Mark G Kris; David G Pfister
Cisplatin versus carboplatin for patients with metastatic non-small-cell lung cancer--an old rivalry renewed.
Journal of the National Cancer Institute 2007;99(11):828-9.
2007: David G Pfister; Allan C Halpern
Skin squamous cell cancer: the time is right for greater involvement of the medical oncologist.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):1953-4.
2007: Ian Ganly; Simon G Talbot; Diane Carlson; Agnes Viale; Ellie Maghami; Iman Osman; Eric Sherman; David G Pfister; Shaokun Chuai; Ashok R Shaha; Dennis H Kraus; Jatin P Shah; Nicholas D Socci; Bhuvanesh Singh
Identification of angiogenesis/metastases genes predicting chemoradiotherapy response in patients with laryngopharyngeal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(11):1369-76.
2007: Matthew G Fury; Andrew J Zahalsky; Richard J Wong; Venkatraman E Seshan; Eric Lis; Lucy E Hann; Timothy B Aliff; William Gerald; Martin Fleisher; David G Pfister
A Phase II study of SU5416 in patients with advanced or recurrent head and neck cancers.
Investigational new drugs 2007;25(2):165-72.
2007: Matthew G Fury; David B Solit; Yungpo Bernard Su; Neal Rosen; Francis M Sirotnak; Robert P Smith; Christopher G Azzoli; Jorge Gomez; Vincent A Miller; Mark G Kris; Barbara A Pizzo; Roxanne Henry; David G Pfister; Naiyer A Rizvi
A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2007;59(4):467-75.
2006: Nancy Y Lee; Fernando F de Arruda; Dev R Puri; Suzanne L Wolden; Ashwatha Narayana; James Mechalakos; Venkatraman E Seshan; Dennis H Kraus; Ashok R Shaha; Jatin P Shah; David G Pfister; Michael J Zelefsky
A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma.
International journal of radiation oncology, biology, physics 2006;66(4):966-74.
2006: David G Pfister; Scott A Laurie; Gregory S Weinstein; William M Mendenhall; David J Adelstein; K. Kian Ang; Gary L Clayman; Susan G Fisher; Arlene A Forastiere; Louis B Harrison; Jean-Louis Lefebvre; Nancy Leupold; Marcy A List; Bernard O O'Malley; Snehal G Patel; Marshall R Posner; Michael A Schwartz; Gregory T Wolf
American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3693-704.
2006: Arlene A Forastiere; Andy Trotti; David G Pfister; Jennifer Rubin Grandis
Head and neck cancer: recent advances and new standards of care.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(17):2603-5.
2006: Yungpo Bernard Su; Andrew J Vickers; Michael J Zelefsky; Dennis H Kraus; Ashok R Shaha; Jatin P Shah; Angel M Serio; Louis B Harrison; George J Bosl; David G Pfister
Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancer.
Cancer journal (Sudbury, Mass.) 2006;12(3):182-8.
2006: David G Pfister; Yungpo Bernard Su; Dennis H Kraus; Suzanne L Wolden; Eric Lis; Timothy B Aliff; Andrew J Zahalsky; Simone Lake; Michael Neil Needle; Ashok R Shaha; Jatin P Shah; Michael J Zelefsky
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(7):1072-8.
2006: William C Chen; Andrew Jackson; Amy Budnick; David G Pfister; Dennis H Kraus; Margie A Hunt; Hilda E Stambuk; Sabine Levegrun; Suzanne L Wolden
Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.
Cancer 2006;106(4):820-9.
2006: David G Pfister; John A Ridge
Induction chemotherapy for larynx preservation: patient selection or therapeutic effect?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(4):540-3.
2006: Fernando F de Arruda; Dev R Puri; Joanne Zhung; Ashwatha Narayana; Suzanne L Wolden; Margie Hunt; Hilda E Stambuk; David G Pfister; Dennis H Kraus; Ashok R Shaha; Jatin P Shah; Nancy Y Lee
Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
International journal of radiation oncology, biology, physics 2006;64(2):363-73.
2006: Suzanne L Wolden; William C Chen; David G Pfister; Dennis H Kraus; Sean L Berry; Michael J Zelefsky
Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience.
International journal of radiation oncology, biology, physics 2006;64(1):57-62.
2005: Jacques Bernier; David G Pfister; Jay S Cooper
Adjuvant chemo- and radiotherapy for poor prognosis head and neck squamous cell carcinomas.
Critical reviews in oncology/hematology 2005;56(3):353-64.
2005: Christopher E Desch; Al B Benson; Mark R Somerfield; Patrick J Flynn; Carol Krause; Charles L Loprinzi; Bruce D Minsky; David G Pfister; Katherine S Virgo; Nicholas J Petrelli
Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(33):8512-9.
2005: Ian Ganly; Snehal G Patel; Jeannette Marie S Matsuo; Bhuvanesh Singh; Dennis H Kraus; Jay O Boyle; Richard J Wong; Nancy Y Lee; David G Pfister; Ashok R Shaha; Jatin P Shah
Postoperative complications of salvage total laryngectomy.
Cancer 2005;103(10):2073-81.
2005: Arlene A Forastiere; K. Kian Ang; David M. Brizel; Bruce Earl Brockstein; Frank Dunphy; David W Eisele; Helmuth Goepfert; Wesley L Hicks; Merrill S Kies; William M Lydiatt; Ellie Maghami; Thomas McCaffrey; Bharat B Mittal; David G Pfister; Harlan A Pinto; Marshall R Posner; John A Ridge; Samant Sandeep; David E Schuller; Jatin P Shah; Sharon Spencer; Andrew Trotti; Richard H Wheeler; Gregory T Wolf; Francis P Worden; Bevan Yueh
Head and neck cancers.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(3):316-91.
2004: Volkert B Wreesmann; Weiji Shi; Howard T Thaler; Ashok Poluri; Dennis H Kraus; David G Pfister; Ashok R Shaha; Jatin P Shah; Pulivarthi H Rao; Bhuvanesh Singh
Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(19):3965-72.
2004: David G Pfister; Al B Benson; Mark R Somerfield
Clinical practice. Surveillance strategies after curative treatment of colorectal cancer.
The New England journal of medicine 2004;350(23):2375-82.
2004: Eric Sherman; David M Rubin; Venkatraman E Seshan; Gary K Schwartz; Vincent A Miller; Mark Radzyner; Hirsch S Ruchlin; David Spriggs; David G Pfister
Using patients as their own controls for cost evaluation of phase I clinical trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(7):1308-14.
2004: David G Pfister; David H Johnson; Christopher G Azzoli; William T Sause; Thomas J Smith; Sherman Baker; Jemi Olak; Diane Stover; John R Strawn; Andrew T Turrisi; Mark R Somerfield
American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(2):330-53.
2003: Jeannette Marie S Matsuo; Snehal G Patel; Bhuvanesh Singh; Richard J Wong; Jay O Boyle; Dennis H Kraus; Ashok R Shaha; Michael J Zelefsky; David G Pfister; Jatin P Shah
Clinical nodal stage is an independently significant predictor of distant failure in patients with squamous cell carcinoma of the larynx.
Annals of surgery 2003;238(3):412-21; discussion 421-2.
2003: Cherry Estilo; Pornchai O-Charoenrat; Ivan Ngai; Snehal G Patel; Pabbathi G Reddy; Su Dao; Ashok R Shaha; Dennis H Kraus; Jay O Boyle; Richard J Wong; David G Pfister; Joseph M Huryn; Ian M Zlotolow; Jatin P Shah; Bhuvanesh Singh
The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2300-6.
2003: Charles L Bennett; Mark R Somerfield; David G Pfister; Cecilia Tomori; Sofia Yakren; Peter B Bach
Perspectives on the value of American Society of Clinical Oncology clinical guidelines as reported by oncologists and health maintenance organizations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(5):937-41.
2002: Bhuvanesh Singh; Volkert B Wreesmann; David G Pfister; Ashok Poluri; Ashok R Shaha; Dennis H Kraus; Jatin P Shah; Pulivarthi H Rao
Chromosomal aberrations in patients with head and neck squamous cell carcinoma do not vary based on severity of tobacco/alcohol exposure.
BMC genetics 2002;3():22.
2002: Richard J Wong; D T Lin; Heiko Schöder; Snehal G Patel; Mithat Gonen; Suzanne L Wolden; David G Pfister; Jatin P Shah; Steven M Larson; Dennis H Kraus
Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(20):4199-208.
2002: Snehal G Patel; Paul A Meyers; Andrew G Huvos; Suzanne L Wolden; Bhuvanesh Singh; Ashok R Shaha; Jay O Boyle; David G Pfister; Jatin P Shah; Dennis H Kraus
Improved outcomes in patients with osteogenic sarcoma of the head and neck.
Cancer 2002;95(7):1495-503.
2002: Bhuvanesh Singh; Archontoula Stoffel; Swarna Gogineni; Ashok Poluri; David G Pfister; Ashok R Shaha; Alok Pathak; George J Bosl; Carlos Cordon-Cardo; Jatin P Shah; Pulivarthi H Rao
Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas.
The American journal of pathology 2002;161(2):365-71.
2002: Rowan T Chlebowski; Nananda F Col; Eric P Winer; Deborah E Collyar; Steven R Cummings; Victor G Vogel; Harold J Burstein; Andrea Eisen; Isaac M Lipkus; David G Pfister
American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3328-43.
2002: Iman Osman; Eric Sherman; Bhuvanesh Singh; Venkatraman E Seshan; Michael J Zelefsky; George J Bosl; Howard I Scher; Jatin P Shah; Ashok R Shaha; Dennis H Kraus; Carlos Cordon-Cardo; David G Pfister
Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(13):2980-7.
2002: Bhuvanesh Singh; Rongou Li; Li Xu; Ashok Poluri; Snehal G Patel; Ashok R Shaha; David G Pfister; Eric Sherman; Andy Goberdhan; Robert M Hoffman; Jatin P Shah
Prediction of survival in patients with head and neck cancer using the histoculture drug response assay.
Head & neck 2002;24(5):437-42.
2002: David G Pfister; John McCaffrey; Andrew J Zahalsky; Gary K Schwartz; Eric Lis; William Gerald; Andrew G Huvos; Jatin P Shah; Dennis H Kraus; Ashok R Shaha; Bhuvanesh Singh; Suzanne L Wolden; Michael J Zelefsky; Ilana Palgi
A phase II trial of bryostatin-1 in patients with metastatic or recurrent squamous cell carcinoma of the head and neck.
Investigational new drugs 2002;20(1):123-7.
2001: Dong M Shin; Nicholas J Donato; Roman Perez-Soler; Hyung Ju C Shin; J Y Wu; P Zhang; KN Lawhorn; Fadlo R Khuri; Bonnie S Glisson; J Myers; Gary L Clayman; David G Pfister; J Falcey; Harlan W Waksal; John Mendelsohn; Waun Ki Hong
Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(5):1204-13.
2001: Suzanne L Wolden; Michael J Zelefsky; Margie A Hunt; Kenneth E Rosenzweig; Lanceford M Chong; Dennis H Kraus; David G Pfister; Steven A Leibel
Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma.
International journal of radiation oncology, biology, physics 2001;49(5):1229-34.
2001: Scott A Laurie; David G Pfister; Mark G Kris; William P Tong; Gregory M Chronowski; Katherine M W Pisters; Robert T Heelan; Francis M Sirotnak
Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3):501-9.
2001: Abram Recht; S B Edge; Lawrence J Solin; D S Robinson; A Estabrook; R E Fine; G F Fleming; Silvia C Formenti; Clifford Hudis; J J Kirshner; D A Krause; Robert R Kuske; A S Langer; G W Sledge; Timothy J Whelan; David G Pfister
Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(5):1539-69.
2001: Eric Sherman; David G Pfister; Hirsch S Ruchlin; D M Rubin; Mark Radzyner; G H Kelleher; Susan F Slovin; W Kevin Kelly; Howard I Scher
The Collection of Indirect and Nonmedical Direct Costs (COIN) form: a new tool for collecting the invisible costs of androgen independent prostate carcinoma.
Cancer 2001;91(4):841-53.
2001: Suzanne L Wolden; Michael J Zelefsky; Dennis H Kraus; Kenneth E Rosenzweig; Lanceford M Chong; Ashok R Shaha; H Zhang; Louis B Harrison; Jatin P Shah; David G Pfister
Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1105-10.
2001: David G Pfister; Eric Sherman; Suzanne L Wolden
A new intensified therapeutic regimen for advanced head and neck squamous cell carcinomas: where does it fit among available treatment options?
Cancer investigation 2001;19(2):217-8.
2000: David G Pfister; K. Kian Ang; Bruce E Brockstein; A Dimitrios Colevas; J Ellenhorn; Helmuth Goepfert; W L Hicks; Waun Ki Hong; M S Kies; William M Lydiatt; T McCaffrey; Bharat B Mittal; John A Ridge; D E Schuller; Jatin P Shah; S Spencer; Andy Trotti; Susan G Urba; Ernest A Weymuller; Richard H Wheeler; Gregory T Wolf
NCCN Practice Guidelines for Head and Neck Cancers.
Oncology (Williston Park, N.Y.) 2000;14(11A):163-94.
2000: Al B Benson; Christopher E Desch; Patrick J Flynn; Carol Krause; Charles L Loprinzi; Bruce D Minsky; Nicholas J Petrelli; David G Pfister; Thomas J Smith; Mark R Somerfield
2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(20):3586-8.
2000: Steven L Soignet; Vincent A Miller; David G Pfister; B J Bienvenu; R Ho; B A Parker; S A Amyotte; A Cato; RP Warrell
Initial clinical trial of a high-affinity retinoic acid receptor ligand (LGD1550).
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(5):1731-5.
2000: bruce hillner; James N Ingle; J R Berenson; Nora Janjan; Kathy S Albain; Allan Lipton; Gary C Yee; J Sybil Biermann; Rowan T Chlebowski; David G Pfister
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(6):1378-91.
2000: Suzanne L Wolden; Peter G Steinherz; Dennis H Kraus; Michael J Zelefsky; David G Pfister; Norma Wollner
Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer.
International journal of radiation oncology, biology, physics 2000;46(4):859-64.
2000: José Baselga; David G Pfister; M Robert Cooper; R Cohen; B Burtness; M Bos; Gabriella D'Andrea-Carlino; Andrew D Seidman; Larry Norton; K Gunnett; J Falcey; V Anderson; Harlan W Waksal; John Mendelsohn
Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(4):904-14.
1999: Gregory T Wolf; Arlene A Forastiere; K. Kian Ang; Bruce E Brockstein; BA Conley; Helmuth Goepfert; Dennis H Kraus; Jean-Louis Lefebvre; Thomas F Pajak; David G Pfister; Susan G Urba
Workshop report: organ preservation strategies in advanced head and neck cancer--current status and future directions.
Head & neck 1999;21(8):689-93.
1999: F Fata; Eileen O'Reilly; David H Ilson; David G Pfister; D Leffel; David P Kelsen; Gary K Schwartz; Ephraim S Casper
Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.
Cancer 1999;86(10):2034-7.
1999: Martee Hensley; Lynn Schuchter; Celeste Lindley; N J Meropol; GARY COHEN; G Broder; W J Gradishar; D M Green; R J Langdon; R B Mitchell; R Negrin; Ted P Szatrowski; J T Thigpen; Daniel Von Hoff; T H Wasserman; Eric P Winer; David G Pfister
American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3333-55.
1999: Richard J Gralla; David Osoba; Mark G Kris; P Kirkbride; Paul J Hesketh; L W Chinnery; Rebecca A Clark-Snow; D P Gill; S Groshen; Steven M Grunberg; Jim M Koeller; Gary R Morrow; Edith A Perez; J H Silber; David G Pfister
Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2971-94.
1999: Eric Sherman; Hirsch S Ruchlin; J S Holden; David G Pfister
Clinical economics of head and neck malignancies.
Hematology/oncology clinics of North America 1999;13(4):867-81.
1999: Rowan T Chlebowski; Deborah E Collyar; Mark R Somerfield; David G Pfister
American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(6):1939-55.
1999: Christopher E Desch; Al B Benson; Thomas J Smith; Patrick J Flynn; Carol Krause; Charles L Loprinzi; Bruce D Minsky; Nicholas J Petrelli; David G Pfister; Mark R Somerfield
Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(4):1312.
1999: Bhuvanesh Singh; Peter G Cordeiro; Eric Santamaria; A R Shaha; David G Pfister; Jatin P Shah
Factors associated with complications in microvascular reconstruction of head and neck defects.
Plastic and reconstructive surgery 1999;103(2):403-11.
1998: Louis B Harrison; Henry J Lee; David G Pfister; Dennis H Kraus; C White; Adam Raben; Michael J Zelefsky; EW Strong; Jatin P Shah
Long term results of primary radiotherapy with/without neck dissection for squamous cell cancer of the base of tongue.
Head & neck 1998;20(8):668-73.
1998: Louis B Harrison; Adam Raben; David G Pfister; Michael J Zelefsky; EW Strong; Jatin P Shah; Ronald H Spiro; Ashok R Shaha; Dennis H Kraus; Stimson P Schantz; E Carper; B Bodansky; C White; George J Bosl
A prospective phase II trial of concomitant chemotherapy and radiotherapy with delayed accelerated fractionation in unresectable tumors of the head and neck.
Head & neck 1998;20(6):497-503.
1998: Arlene A Forastiere; Helmuth Goepfert; D Goffinet; K W Hong; George Laramore; B Mittal; David G Pfister; John A Ridge; D Schuller; Jatin P Shah; S Spencer; Susan G Urba; Gregory T Wolf
NCCN practice guidelines for head and neck cancer. National Comprehensive Cancer Network.
Oncology (Williston Park, N.Y.) 1998;12(7A):39-147.
1998: Ephraim S Casper; RJ Waltzman; Gary K Schwartz; A Sugarman; David G Pfister; David H Ilson; James M Woodruff; Denis Leung; Joseph R Bertino
Phase II trial of paclitaxel in patients with soft-tissue sarcoma.
Cancer investigation 1998;16(7):442-6.
1998: David G Pfister; Hirsch S Ruchlin; Elena B Elkin
Health services research in head and neck cancer.
Cancer treatment and research 1998;97():159-75.
1997: David G Pfister; Ashok R Shaha; Louis B Harrison
The role of chemotherapy in the curative treatment of head and neck cancer.
Surgical oncology clinics of North America 1997;6(4):749-68.
1997: Henry J Lee; Michael J Zelefsky; Dennis H Kraus; David G Pfister; EW Strong; Adam Raben; Jatin P Shah; Louis B Harrison
Long-term regional control after radiation therapy and neck dissection for base of tongue carcinoma.
International journal of radiation oncology, biology, physics 1997;38(5):995-1000.
1997: David G Pfister; Hirsch S Ruchlin; Elena B Elkin
Economic considerations in the care of patients with head and neck malignancies.
Current opinion in oncology 1997;9(3):241-6.
1997: Louis B Harrison; Michael J Zelefsky; David G Pfister; E Carper; Adam Raben; Dennis H Kraus; EW Strong; A Rao; Howard T Thaler; Tatyana Polyak; Russell Portenoy
Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue.
Head & neck 1997;19(3):169-75.
1997: Vincent A Miller; FM Benedetti; JR Rigas; A L Verret; David G Pfister; David J Straus; Mark G Kris; M Crisp; R Heyman; GR Loewen; JA Truglia; RP Warrell
Initial clinical trial of a selective retinoid X receptor ligand, LGD1069.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):790-5.
1996: Katherine M W Pisters; L B Tyson; William Tong; Martin Fleisher; Vincent A Miller; Stefan C Grant; David G Pfister; J R Rigas; C L Densmore; G Krol; Robert T Heelan; Francis M Sirotnak; Joseph R Bertino; Mark G Kris
High-dose edatrexate with oral leucovorin rescue: a phase I and clinical pharmacological study in adults with advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(11):1819-24.
1996: J Weeks; David G Pfister
Outcomes research studies.
Oncology (Williston Park, N.Y.) 1996;10(11 Suppl):29-34.
1996: Michael J Zelefsky; Dennis H Kraus; David G Pfister; Adam Raben; Jatin P Shah; EW Strong; Ronald H Spiro; George J Bosl; Louis B Harrison
Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer.
Head & neck 1996;18(5):405-11.
1995: Dennis H Kraus; David G Pfister; Louis B Harrison; Ronald H Spiro; EW Strong; Michael J Zelefsky; George J Bosl; Jatin P Shah
Salvage laryngectomy for unsuccessful larynx preservation therapy.
The Annals of otology, rhinology, and laryngology 1995;104(12):936-41.
1995: W Kevin Kelly; Howard I Scher; Madhu Mazumdar; David G Pfister; T Curley; C Leibertz; L Cohen; V Vlamis; Ann M Dnistrian; Morton K Schwartz
Suramin and hydrocortisone: determining drug efficacy in androgen-independent prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(9):2214-22.
1995: Vincent A Miller; J R Rigas; Katherine M W Pisters; Stefan C Grant; David G Pfister; Robert T Heelan; Mark G Kris
Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapy.
American journal of clinical oncology 1995;18(4):303-6.
1995: R Tavorath; David G Pfister
Chemotherapy for recurrent disease and combined modality therapies for head and neck cancer.
Current opinion in oncology 1995;7(3):242-7.
1995: David G Pfister; Louis B Harrison; EW Strong; Jatin P Shah; R W Spiro; Dennis H Kraus; J G Armstrong; Michael J Zelefsky; D E Fass; M H Weiss
Organ-function preservation in advanced oropharynx cancer: results with induction chemotherapy and radiation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):671-80.
1995: David G Pfister
Chemotherapy in locally advanced, squamous cell head and neck cancer: limitations, lessons learned, and evolving standards of care.
Cancer investigation 1995;13(1):134-6.
1994: Dennis H Kraus; David G Pfister; Louis B Harrison; Jatin P Shah; Ronald H Spiro; J G Armstrong; D E Fass; Michael J Zelefsky; Stimson P Schantz; M H Weiss
Larynx preservation with combined chemotherapy and radiation therapy in advanced hypopharynx cancer.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1994;111(1):31-7.
1994: Louis B Harrison; David G Pfister; Dennis H Kraus; J G Armstrong; Michael J Zelefsky; J Wiseberg; George J Bosl; E W Strong; Jatin P Shah
Management of unresectable malignant tumors at the skull base using concomitant chemotherapy and radiotherapy with accelerated fractionation.
Skull base surgery 1994;4(3):127-31.
1994: David G Pfister; Dean F Bajorin; Robert J Motzer; Howard I Scher; C Louison; Louis B Harrison; Jatin P Shah; EW Strong; George J Bosl
Cisplatin, fluorouracil, and leucovorin. Increased toxicity without improved response in squamous cell head and neck cancer.
Archives of otolaryngology--head & neck surgery 1994;120(1):89-95.
1994: Thomas D Schiano; David G Pfister; Louis B Harrison; Moshe Shike
Neoplastic seeding as a complication of percutaneous endoscopic gastrostomy.
The American journal of gastroenterology 1994;89(1):131-3.
1993: J Armstrong; David G Pfister; EW Strong; R Heimann; Dennis H Kraus; A Polishook; Michael J Zelefsky; George J Bosl; Jatin P Shah; Ronald H Spiro
The management of the clinically positive neck as part of a larynx preservation approach.
International journal of radiation oncology, biology, physics 1993;26(5):759-65.
1993: Dean F Bajorin; M F Sarosdy; David G Pfister; Madhu Mazumdar; Robert J Motzer; Howard I Scher; N L Geller; W R Fair; Harry W Herr; Pramod C Sogani
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(4):598-606.
1993: David G Pfister; Dean F Bajorin; Robert J Motzer; Howard I Scher; C Louison; Louis B Harrison; Jatin P Shah; EW Strong; George J Bosl
A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancer.
Investigational new drugs 1993;11(1):53-6.
1992: Louis B Harrison; Michael J Zelefsky; Roy B Sessions; D E Fass; J G Armstrong; David G Pfister; EW Strong
Base-of-tongue cancer treated with external beam irradiation plus brachytherapy: oncologic and functional outcome.
Radiology 1992;184(1):267-70.
1992: David G Pfister; Louis B Harrison; E W Strong; George J Bosl
Current status of larynx preservation with multimodality therapy.
Oncology (Williston Park, N.Y.) 1992;6(3):33-8, 43; discussion 44, 47.
1991: Louis B Harrison; David G Pfister; D E Fass; J G Armstrong; Roy B Sessions; Jatin P Shah; Ronald H Spiro; EW Strong; S Weisen; George J Bosl
Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer.
International journal of radiation oncology, biology, physics 1991;21(3):703-8.
1991: David G Pfister; EW Strong; Louis B Harrison; I E Haines; D A Pfister; Roy B Sessions; Ronald H Spiro; Jatin P Shah; F Gerold; T McLure
Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(5):850-9.
1991: Robert J Motzer; E Rodriguez; Victor E Reuter; F Samaniego; Ethan Dmitrovsky; Dean F Bajorin; David G Pfister; N Z Parsa; Raju S K Chaganti; George J Bosl
Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies.
Journal of the National Cancer Institute 1991;83(5):341-6.
1991: Louis B Harrison; David G Pfister; George J Bosl
Chemotherapy as part of the initial treatment for nasopharyngeal cancer.
Oncology (Williston Park, N.Y.) 1991;5(2):67-70;discussion 70-1,74,79 passim.
1991: George J Bosl; EW Strong; Louis B Harrison; David G Pfister
Chemotherapy and the management of locally advanced squamous cell carcinoma of the head and neck: role in larynx preservation.
Important advances in oncology 1991;():191-203.
1991: David G Pfister; George J Bosl
BOMM: new solution or old problem?
Cancer investigation 1991;9(5):605-6.
1990: David G Pfister; Carolyn K Wells; C K Chan; A R Feinstein
Classifying clinical severity to help solve problems of stage migration in nonconcurrent comparisons of lung cancer therapy.
Cancer research 1990;50(15):4664-9.
1990: Robert J Motzer; K Cooper; N L Geller; David G Pfister; S Y Lin; Dean F Bajorin; Howard I Scher; Harry W Herr; W Fair; M Morse
Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors.
Cancer 1990;65(11):2465-70.
1990: Carolyn K Wells; C K Chan; E B Milstone; David G Pfister; Alvan R Feinstein
Diagnostic criteria and technology as sources for changing incidences of pulmonary diseases.
The American journal of medicine 1990;88(2):117-22.
1988: B Vikram; George J Bosl; David G Pfister; W Assad; EW Strong; Ronald H Spiro; Roy B Sessions; F P Gerold; Jatin P Shah
New strategies for avoiding total laryngectomy in patients with head and neck cancer.
NCI monographs : a publication of the National Cancer Institute 1988;(6):361-4.
1987: I Haines; George J Bosl; David G Pfister; Ronald H Spiro; F Gerold; Roy B Sessions; Jatin P Shah; EW Strong; B Vikram; Louis B Harrison
Very-high-dose cisplatin with bleomycin infusion as initial treatment of advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(10):1594-600.
1987: David G Pfister; R I Horwitz
The rightward shift of colon cancer. Aging or artifact?
Journal of clinical gastroenterology 1987;9(1):58-61.